galactose has been researched along with amphotericin b in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (7.89) | 18.7374 |
| 1990's | 3 (7.89) | 18.2507 |
| 2000's | 16 (42.11) | 29.6817 |
| 2010's | 14 (36.84) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Fantini, J; Marvaldi, J; Mauchamp, J; Verrier, B | 1 |
| Achord, JL; Fales, FW; Patterson, JH; Pruitt, AW | 1 |
| Hara, K; Hashimoto, A; Kakeya, H; Koga, H; Kohno, S; Mitsutake, K; Miyazaki, T; Yamamoto, Y; Yanagihara, K | 1 |
| Bacher, J; Francesconi, A; Francis, P; Hoffman, A; Lee, JW; Peter, J; Pizzo, PA; Shelhamer, J; Walsh, TJ | 1 |
| Brinkman, K; Kremer, HP; Kullberg, BJ; Meis, JF; Verweij, PE | 1 |
| Chandra, J; Douglas, LJ; Faddoul, FF; Ghannoum, MA; Hoyer, LL; Leidich, SD; Mukherjee, PK | 1 |
| Bonaly, R; Coulon, J; Fessi, H; Kassab, R; Menaucourt, J; Parrot-Lopez, H | 1 |
| Bakker-Woudenberg, IA; Becker, MJ; de Marie, S; Fens, MH; Hop, WC; Verbrugh, HA | 1 |
| Brahim, JJ; Bredius, RG; Corrin, B; Gesink-vd Veer, BJ; Hiltermann, TJ; Rabe, KF | 1 |
| Bakker-Woudenberg, IA; Becker, MJ; de Marie, S; Fens, MH; Verbrugh, HA | 1 |
| Armstrong, D; Avila, NA; Bacher, J; Groll, AH; Hemmings, M; Lyman, CA; Mickiene, D; Peter, J; Petraitiene, R; Petraitis, V; Roussillon, K; Walsh, TJ | 1 |
| Puig de la Bellacasa, J; Rovira Tarrats, M | 1 |
| Mendlovic, S; Segal, E; Sionov, E | 1 |
| Boogaerts, M; Lagrou, K; Maertens, J; Theunissen, K; Van Eldere, J; Verbeken, E; Verhaegen, J; Verhoef, G; Verschakelen, J; Wilmer, A | 1 |
| Bartlett, K; Risovic, V; Rosland, M; Sivak, O; Wasan, KM | 2 |
| Ahmad, S; Halim, MA; Khan, ZU; McGinnis, MR; Mokaddas, E; Nair, MP; Nampoory, MR; Said, T | 1 |
| Bacher, J; Bermudez, L; Cotten, CJ; Cotton, MP; Drusano, GL; Francesconi, A; Hope, WW; Hughes, JE; Kasai, M; Kelaher, AM; Kruhlak, MJ; Lyman, CA; Maugel, TK; Mickiene, D; Peter, J; Petraitiene, R; Petraitis, V; Sein, T; Tripathi, S; Walsh, TJ; Wingard, JR; Zerfas, PM | 1 |
| Abrahamsen, TG; Gaustad, P; Warris, A; Winn, RM | 1 |
| Maertens, J; Meersseman, W; Van Bleyenbergh, P | 1 |
| Akashi, K; Eriguchi, Y; Harada, M; Kadowaki, M; Maehara, Y; Miyake, N; Nagasaki, Y; Shimono, N; Uchida, Y | 1 |
| Aghamolla, T; Bacher, J; Hope, WW; Petraitiene, R; Petraitis, V; Walsh, TJ | 1 |
| Cheah, FK; Chlebicka, NL; Goh, YT; Kurup, A; Lin, RT; Low, JG; Tan, BH; Wong, GC | 1 |
| Jones, B; Kirkpatrick, WR; Lappin, DF; McCulloch, E; Patterson, TF; Rajendran, R; Ramage, G; Shrief, R; Warn, P; Williams, C | 1 |
| Al-Saigh, R; Meletiadis, J; Roilides, E; Velegraki, A; Walsh, TJ; Zerva, L | 1 |
| Calvo, E; Fothergill, AW; Guarro, J; Mayayo, E; Pastor, FJ; Rinaldi, MG; Salas, V; Sutton, DA | 1 |
| Al-Saigh, R; Meletiadis, J; Siafakas, N; Siopi, M; Velegraki, A; Zerva, L | 1 |
| Chai, LY; Earnest, A; Herbrecht, R; Johnson, EM; Kullberg, BJ; Netea, MG; Schlamm, HT; Teerenstra, S; Troke, PF; Vonk, AG | 1 |
| Feng, R; Li, S; Wang, D; Xu, N | 1 |
| Barnes, R; Bow, E; Charbonneau, C; Earnshaw, S; Herbrecht, R; Kantecki, M; Maertens, J; McDade, C; Morrissey, O; Schlamm, H; Slavin, M; Weinstein, D | 1 |
| Beitz, A; Ehmer, U; Eser, S; Fekecs, L; Huber, W; Lahmer, T; Messer, M; Schmid, RM | 1 |
| Goldraich, L; Husain, S; Kabbani, D; Ross, H; Rotstein, C | 1 |
| Ashworth, A; Barker, J; Felton, TW; Foden, P; Geraghty, CG; Muldoon, EG; Richardson, MD; Rodriguez-Goncer, I; Thomas, S | 1 |
| Abe, R; Hasegawa, N; Hashida, R; Hatano, M; Karigane, D; Kato, J; Kikuchi, T; Mori, T; Okamoto, S; Sakurai, M; Shibuya, K; Wakayama, M; Yamane, Y | 1 |
| Bellissant, E; Berneau, P; Foulquier, JB; Frérou, A; Lemaitre, F; Petitcollin, A; Saint-Marcoux, F; Tron, C; Verdier, MC | 1 |
| Dupont, D; Miailhes, P; Mouchel, R; Persat, F; Saison, J; Wallon, M | 1 |
| Aboutalebian, S; Fakhim, H; Hajiahmadi, S; Hakamifard, A; Hashemi, M; Mohammadi, R | 1 |
| SUBAK-SHARPE, H | 1 |
2 review(s) available for galactose and amphotericin b
| Article | Year |
|---|---|
New therapies for fungal pneumonia.
Topics: Amphotericin B; Antifungal Agents; Fungi; Galactose; Humans; Mannans; Mycoses; Pneumonia; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Triazoles; Voriconazole | 2009 |
Invasive hepatic mucormycosis: A case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Autopsy; Fatal Outcome; Ferritins; Galactose; Humans; Invasive Fungal Infections; Liver Diseases; Male; Mannans; Mucormycosis; Primary Myelofibrosis; Spleen | 2019 |
3 trial(s) available for galactose and amphotericin b
| Article | Year |
|---|---|
[Aspergillus galactomannan detection in allogenic hematopoietic cell transplantation].
Topics: Adolescent; Adult; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus; Biomarkers; Enzyme-Linked Immunosorbent Assay; False Negative Reactions; Female; Fungemia; Galactose; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Male; Mannans; Middle Aged; Predictive Value of Tests; Prospective Studies; Transplantation Conditioning; Transplantation, Homologous | 2003 |
Galactomannan-guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Caspofungin; Drug Therapy, Combination; Echinocandins; Female; Fever; Galactose; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Opportunistic Infections; Prospective Studies; Pyrimidines; Radiography, Thoracic; Risk Factors; Singapore; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2011 |
Voriconazole or amphotericin B as primary therapy yields distinct early serum galactomannan trends related to outcomes in invasive aspergillosis.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Biomarkers; Female; Fungal Polysaccharides; Galactose; Hematologic Neoplasms; Humans; Male; Mannans; Pyrimidines; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2014 |
33 other study(ies) available for galactose and amphotericin b
| Article | Year |
|---|---|
In vitro differentiated HT 29-D4 clonal cell line generates leakproof and electrically active monolayers when cultured in porous-bottom culture dishes.
Topics: Adenocarcinoma; Amphotericin B; Cell Differentiation; Cells, Cultured; Galactose; Humans; Intercellular Junctions; Membrane Potentials; Microscopy, Electron; Tumor Cells, Cultured | 1989 |
Glucose-galactose malabsorption complicated by monilial arthritis.
Topics: Amphotericin B; Arthritis, Infectious; Candidiasis; Dehydration; Diarrhea; Diet Therapy; Fructose; Galactose; Glucose; Humans; Infant; Malabsorption Syndromes; Mitosporic Fungi | 1969 |
Detection of (1-3)-beta-D-glucan in a rat model of aspergillosis.
Topics: Amphotericin B; Animals; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Disease Models, Animal; Galactose; Glucans; Horseshoe Crabs; Lung; Male; Mannans; Rats; Rats, Sprague-Dawley | 1995 |
Efficacy of unilamellar liposomal amphotericin B in treatment of pulmonary aspergillosis in persistently granulocytopenic rabbits: the potential role of bronchoalveolar D-mannitol and serum galactomannan as markers of infection.
Topics: Agranulocytosis; Amphotericin B; Animals; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Biomarkers; Bronchoalveolar Lavage Fluid; Ergosterol; Galactose; Kidney Diseases; Life Tables; Liposomes; Lung Diseases; Mannans; Mannitol; Opportunistic Infections; Rabbits; Survival Analysis | 1994 |
Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management.
Topics: Aged; Amphotericin B; Antibodies, Fungal; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; DNA, Fungal; Drug Resistance, Microbial; Female; Galactose; Humans; Mannans; Meningitis, Fungal; Mycology; Polymerase Chain Reaction; Pyrimidines; Time Factors; Triazoles; Voriconazole | 1999 |
Antifungal resistance of candidal biofilms formed on denture acrylic in vitro.
Topics: Acrylic Resins; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Biofilms; Candida albicans; Candidiasis, Oral; Chlorhexidine; Colony Count, Microbial; Denture Bases; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Fluconazole; Galactose; Glucose; Humans; Indicators and Reagents; Nystatin; Polymethyl Methacrylate; Saliva; Statistics as Topic; Stomatitis, Denture; Sucrose; Tetrazolium Salts; Time Factors | 2001 |
Molecular recognition by Kluyveromyces of amphotericin B-loaded, galactose-tagged, poly (lactic acid) microspheres.
Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Galactose; Glycolates; Kluyveromyces; Lactic Acid; Logistic Models; Microscopy, Atomic Force; Microspheres; Molecular Structure; Molecular Weight; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Substrate Specificity | 2002 |
Enhanced antifungal efficacy in experimental invasive pulmonary aspergillosis by combination of AmBisome with Fungizone as assessed by several parameters of antifungal response.
Topics: Agranulocytosis; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Biomarkers; Chitin; Drug Therapy, Combination; Female; Galactose; Lung; Mannans; Rats; Survival Analysis; Time Factors | 2002 |
Bilateral cavitary pulmonary consolidations in a patient undergoing allogeneic bone marrow transplantation for acute leukemia.
Topics: Acute Disease; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Bronchoalveolar Lavage Fluid; Child; Enzyme-Linked Immunosorbent Assay; Fatal Outcome; Galactose; Humans; Leukemia, Myeloid; Lung Diseases, Fungal; Male; Mannans; Postoperative Complications | 2003 |
Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Chitin; Colony Count, Microbial; Cytokines; Enzyme-Linked Immunosorbent Assay; Female; Galactose; Kinetics; Lung; Mannans; Neutropenia; Rats; Survival Analysis | 2003 |
Efficacy, safety, and plasma pharmacokinetics of escalating dosages of intravenously administered ravuconazole lysine phosphoester for treatment of experimental pulmonary aspergillosis in persistently neutropenic rabbits.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Dose-Response Relationship, Drug; Female; Galactose; Half-Life; Image Processing, Computer-Assisted; Immunosuppressive Agents; Injections, Intravenous; Lung; Mannans; Microbial Sensitivity Tests; Neutropenia; Rabbits; Survival Analysis; Tetrazolium Salts; Thiazoles; Tomography, X-Ray Computed; Triazoles | 2004 |
Experimental systemic murine aspergillosis: treatment with polyene and caspofungin combination and G-CSF.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Female; Galactose; Granulocyte Colony-Stimulating Factor; Immunocompromised Host; Kidney; Lipopeptides; Liposomes; Lung; Mannans; Mice; Mice, Inbred ICR; Peptides, Cyclic; Polyenes; Survival Rate | 2005 |
Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study.
Topics: Adolescent; Adult; Aged; Algorithms; Amphotericin B; Antifungal Agents; Aspergillosis; Feasibility Studies; Female; Galactose; Humans; Lung Diseases, Fungal; Male; Mannans; Middle Aged; Mycoses; Neutropenia; Prospective Studies; Risk Factors; Tomography, X-Ray Computed | 2005 |
Assessing the antifungal activity, pharmacokinetics, and tissue distribution of amphotericin B following the administration of Abelcet and AmBisome in combination with caspofungin to rats infected with Aspergillus fumigatus.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Caspofungin; Colony Count, Microbial; Disease Models, Animal; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Echinocandins; Galactose; Injections, Intravenous; Lipopeptides; Male; Mannans; Peptides, Cyclic; Phosphatidylcholines; Phosphatidylglycerols; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2007 |
Cerebral aspergillosis diagnosed by detection of Aspergillus flavus-specific DNA, galactomannan and (1-->3)-beta-D-glucan in clinical specimens.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus flavus; beta-Glucans; Brain; Brain Diseases; Caspofungin; Diagnosis, Differential; DNA, Fungal; Echinocandins; Electrophoresis, Agar Gel; Galactose; Humans; Lipopeptides; Male; Mannans; Middle Aged; Peptides, Cyclic; Polymerase Chain Reaction | 2007 |
Pathogenesis of Aspergillus fumigatus and the kinetics of galactomannan in an in vitro model of early invasive pulmonary aspergillosis: implications for antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Arteries; Aspergillosis; Aspergillus fumigatus; Cell Line, Tumor; Endothelial Cells; Galactose; Humans; In Vitro Techniques; Kinetics; Lung; Lung Diseases, Fungal; Macrophages; Mannans; Models, Biological; Monte Carlo Method | 2007 |
Assessing the antifungal activity of a new oral lipid-based amphotericin B formulation following administration to rats infected with Aspergillus fumigatus.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Antigens, Fungal; Aspergillosis; Aspergillus fumigatus; Brain; Galactose; Intestinal Absorption; Male; Mannans; Oleic Acids; Rats; Rats, Sprague-Dawley; Spleen; Stem Cells | 2007 |
The effect of antifungal agents and human monocytes on in vitro galactomannan release by Aspergillus spp. in liquid culture medium.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Cells, Cultured; Coculture Techniques; Culture Media; Fluconazole; Galactose; Humans; Itraconazole; Mannans; Monocytes | 2007 |
Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Drug Therapy, Combination; Echinocandins; Female; Galactose; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Kidney; Lipopeptides; Lung; Mannans; Micafungin; Mice; Mice, Inbred ICR; Spleen; Survival Analysis | 2009 |
The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3) β-d-glucan and consequences of delayed antifungal therapy.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; beta-Glucans; Deoxycholic Acid; Drug Combinations; Galactose; Invasive Pulmonary Aspergillosis; Mannans; Proteoglycans; Rabbits | 2010 |
Antifungal treatment affects the laboratory diagnosis of invasive aspergillosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillus fumigatus; Biomarkers; Caspofungin; Disease Models, Animal; DNA, Fungal; Early Diagnosis; Echinocandins; Galactose; Immunoenzyme Techniques; Invasive Pulmonary Aspergillosis; Lipopeptides; Mannans; Microbiological Techniques; Mycological Typing Techniques; Predictive Value of Tests; Rats; Real-Time Polymerase Chain Reaction; Time Factors; Triazoles | 2012 |
Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Aspergillus flavus; Aspergillus fumigatus; Caspofungin; Diffusion Chambers, Culture; Echinocandins; Galactose; Humans; Lipopeptides; Mannans; Microbial Sensitivity Tests; Pulsatile Flow; Pyrimidines; Species Specificity; Spores, Fungal; Triazoles; Voriconazole | 2012 |
MIC values of voriconazole are predictive of treatment results in murine infections by Aspergillus terreus species complex.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus; Drug Resistance, Fungal; Galactose; Male; Mannans; Mice; Microbial Sensitivity Tests; Prognosis; Pyrimidines; Survival Analysis; Triazoles; Voriconazole | 2013 |
Single-dose pharmacodynamics of amphotericin B against Aspergillus species in an in vitro pharmacokinetic/pharmacodynamic model.
Topics: Amphotericin B; Antifungal Agents; Aspergillus flavus; Aspergillus fumigatus; Culture Media; Galactose; Humans; Mannans; Microbial Sensitivity Tests; Models, Biological; Time Factors | 2013 |
[The clinical monitoring of invasive aspergillosis in surgical intensive care unit during 10 years].
Topics: Amphotericin B; Aspergillosis; Critical Care; Galactose; Humans; Incidence; Intensive Care Units; Mannans; Prognosis; Retrospective Studies; Risk Factors | 2014 |
Economic Comparison of an Empirical Versus Diagnostic-Driven Strategy for Treating Invasive Fungal Disease in Immunocompromised Patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Caspofungin; Cost Savings; Decision Trees; Deoxycholic Acid; Drug Combinations; Echinocandins; Febrile Neutropenia; Galactose; Health Care Costs; Health Resources; Humans; Immunocompromised Host; Lipopeptides; Mannans; Survival Rate; Voriconazole | 2015 |
Pseudallescheria boydii with Aspergillus fumigatus and Aspergillus terreus in a Critically Ill Hematopoietic Stem Cell Recipient with ARDS.
Topics: Aged; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; beta-Glucans; Clarithromycin; Coinfection; Critical Illness; Extracorporeal Membrane Oxygenation; Galactose; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Linezolid; Male; Mannans; Meropenem; Pneumonia; Pseudallescheria; Severe Acute Respiratory Syndrome; Thienamycins; Transplant Recipients; Voriconazole | 2016 |
Outbreak of invasive aspergillosis in heart transplant recipients: The role of screening computed tomography scans in asymptomatic patients and universal antifungal prophylaxis.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antibiotic Prophylaxis; Antifungal Agents; Asymptomatic Diseases; Cohort Studies; Disease Outbreaks; Echinocandins; Female; Galactose; Heart Transplantation; Hematologic Neoplasms; Humans; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Mass Screening; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Tomography, X-Ray Computed; Transplant Recipients; Voriconazole | 2018 |
Invasive pulmonary aspergillosis is associated with adverse clinical outcomes in critically ill patients receiving veno-venous extracorporeal membrane oxygenation.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Critical Illness; Echinocandins; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Immunocompromised Host; Influenza, Human; Invasive Pulmonary Aspergillosis; Lipopeptides; Male; Mannans; Micafungin; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; Voriconazole; Young Adult | 2018 |
Liposomal amphotericin B pharmacokinetics in a patient treated with extracorporeal membrane oxygenation.
Topics: Adult; Amphotericin B; Antifungal Agents; Antigens, Fungal; Area Under Curve; Bronchoalveolar Lavage Fluid; Extracorporeal Membrane Oxygenation; Female; Galactose; Humans; Invasive Pulmonary Aspergillosis; Liposomes; Mannans; Respiratory Distress Syndrome | 2019 |
Aspergillus endophthalmitis: Potential role for vitreous galactomannan testing?
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Endophthalmitis; Eye Infections, Fungal; Female; Galactose; Humans; Male; Mannans; Middle Aged; Visual Acuity; Vitrectomy; Vitreous Body; Voriconazole | 2020 |
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus.
Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus ochraceus; Biomarkers; Brain Abscess; Bronchoalveolar Lavage Fluid; COVID-19; COVID-19 Nucleic Acid Testing; Fatal Outcome; Galactose; Humans; Immunocompetence; Invasive Fungal Infections; Lung Diseases, Fungal; Male; Mannans; SARS-CoV-2; Voriconazole | 2021 |
BIOCHEMICALLY MARKED VARIANTS OF THE SYRIAN HAMSTER FIBROBLAST CELL LINE BHK21 AND ITS DERIVATIVES.
Topics: 2-Aminopurine; Amphotericin B; Animals; Antineoplastic Agents; Azaguanine; Bromodeoxyuridine; Carbon Isotopes; Cell Division; Cell Line; Cricetinae; Dactinomycin; Fibroblasts; Floxuridine; Fluorouracil; Hexoses; Hypoxanthines; Mercaptopurine; Mesocricetus; Metabolism; Mitomycin; Mitomycins; Mutation; Nucleosides; Pharmacology; Puromycin; Research; Thioguanine; Tissue Culture Techniques; Tritium; Vinblastine | 1965 |